Edgewise Therapeutics Inc (NASDAQ: EWTX) is 1.50% higher on its value in year-to-date trading and has touched a low of $14.90 and a high of $38.12 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The EWTX stock was last observed hovering at around $26.67 in the last trading session, with the day’s gains setting it 0.43%.
Currently trading at $27.10, the stock is -1.07% and -2.99% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.58 million and changing 1.61% at the moment leaves the stock 10.59% off its SMA200. EWTX registered 56.02% gain for a year compared to 6-month gain of 44.00%.
The stock witnessed a -1.06% loss in the last 1 month and extending the period to 3 months gives it a -13.80%, and is 4.84% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 6.45% over the week and 6.07% over the month.
Edgewise Therapeutics Inc (EWTX) has around 88 employees, a market worth around $2.57B and $0.00M in sales. Distance from 52-week low is 81.88% and -28.91% from its 52-week high. The company has generated returns on investments over the last 12 months (-25.25%).
The EPS is expected to grow by 5.75% this year, but quarterly earnings will post 0.00% year-over-year. Quarterly sales are estimated to shrink 0.00% in year-over-year returns.
The shares outstanding are 94.41M, and float is at 65.86M with Short Float at 10.71%.
The top institutional shareholder in the company is ORBIMED ADVISORS LLC with over 15.02 million shares valued at $270.54 million. The investor’s holdings represent 16.0634 of the EWTX Shares outstanding. As of 2024-06-30, the second largest holder is RA CAPITAL MANAGEMENT, L.P. with 8.91 million shares valued at $160.45 million to account for 9.5269 of the shares outstanding. The other top investors are BLACKROCK INC. which holds 6.02 million shares representing 6.8698 and valued at over $108.34 million, while NOVO HOLDINGS A/S holds 6.7844 of the shares totaling 6.34 million with a market value of $114.26 million.
Edgewise Therapeutics Inc (EWTX) Insider Activity
The most recent transaction is an insider sale by Russell Alan J, the company’s Chief Scientific Officer. SEC filings show that Russell Alan J sold 8,015 shares of the company’s common stock on Feb 05 ’25 at a price of $30.02 per share for a total of $0.24 million. Following the sale, the insider now owns 14863.0 shares.
Edgewise Therapeutics Inc disclosed in a document filed with the SEC on Feb 06 ’25 that Russell Alan J (Chief Scientific Officer) sold a total of 1,200 shares of the company’s common stock. The trade occurred on Feb 06 ’25 and was made at $30.13 per share for $36153.0. Following the transaction, the insider now directly holds 14863.0 shares of the EWTX stock.
Still, SEC filings show that on Feb 05 ’25, KOCH KEVIN (President and CEO) disposed off 8,636 shares at an average price of $30.03 for $0.26 million. The insider now directly holds 14,478 shares of Edgewise Therapeutics Inc (EWTX).
